Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-03-23

Clinical Trial Update: Role Of Phosphorus And FGF 23 In Patients With Dent Disease [Phase 1, Phase 2]

View source ↗

Summary

A completed clinical trial update exploring the role of phosphorus and FGF23 in patients with Dent disease, covering Phase 1 and Phase 2 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Dent Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-03-23